MORGAN STANLEY PLC/CALL/BECTON DICKINSON AND CO./310/0.1/20.12.24 Share Price

Warrant

DE000MG03854

Market Closed - Börse Stuttgart 10:27:55 28/06/2024 pm IST
0.24 EUR +22.45% Intraday chart for MORGAN STANLEY PLC/CALL/BECTON DICKINSON AND CO./310/0.1/20.12.24
Current month+155.32%
1 month+185.71%
Date Price Change
28/24/28 0.24 +22.45%
27/24/27 0.196 -1.51%
26/24/26 0.199 -5.69%
25/24/25 0.211 +0.48%
24/24/24 0.21 -4.55%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 10:27 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN MG0385
ISINDE000MG03854
Date issued 12/03/2024
Strike 310 $
Maturity 20/12/2024 (174 Days)
Parity 10 : 1
Emission price 0.24
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.32
Lowest since issue 0.077
Spread 0.03
Spread %10.71%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
233.7 USD
Average target price
279.2 USD
Spread / Average Target
+19.46%
Consensus